SpectronRx
Bill Monachino serves as the Chief Business Officer at SpectronRx since August 2022, overseeing the Accounting, IT, Marketing, and Human Resources departments of a leading Radiopharmaceutical Company. Previous experience includes serving as CIO and SVP at SpectronRx, where Bill directed the strategic and operational standards for the company's IT organization across multiple locations. Prior to that, Bill held the position of Executive Vice President at Global CI for two years after selling a firm, MMY Consulting, Inc., which Bill founded and grew into one of the top 30 Healthcare Consulting Firms in the U.S. Bill's earlier roles include Regional Vice President at Computer Associates, Business Development/Sales/Management at CTG, and Sales Executive at Cap Gemini Sogeti. Bill holds a Bachelor's degree in Business from The University of Akron and has additional educational backgrounds from Xavier University and Padua.
This person is not in any teams
This person is not in any offices
SpectronRx
1 followers
SpectronRx is a CDMO that is FDA and EMA inspected. We are licensed to handle multiple Therapeutic and Diagnostic isotopes pharmaceutical grade including Pb-212, Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. Spectron provides labeling and contract manufacturing services as it relates to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.